prescription-only medicines

Views & Analysis

On 28 September 2022, the international and European self-regulatory bodies for the research-based pharmaceutical industry (I

News

Isomab has presented landmark safety data at ESC, clearing the path for next-generation therapies to promote blood vessel growth in CAD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.